ACR TI-RADS Score combined with cytopathology classification improves the risk stratification of indeterminate thyroid nodules.
Minerva Endocrinol (Torino)
; 2023 Apr 06.
Article
em En
| MEDLINE
| ID: mdl-37021922
ABSTRACT
BACKGROUND:
The aim of this retrospective study was the elaboration of a new diagnostic model that integrate cytological reports (2017 Bethesda System for Reporting Thyroid Cytopathology) with ultrasonographic features (based on ACR TI-RADS score) to achieve a more accurate definition of indeterminate thyroid nodule malignancy risk.METHODS:
Ninety patients submitted to thyroidectomy were divided in three classes low malignancy risk (AUS/FLUS with TI-RADS 2/TI-RADS 3 and FN/SFN with TI-RADS 2), intermediate malignancy risk (AUS/FLUS with TI-RADS 4/TI-RADS 5 and FN/SFN with TI-RADS 3/TI-RADS 4), and high malignancy risk (FN/SFN with TI-RADS 5).RESULTS:
The surgical approach should be recommended in high-risk patients (81.82% of malignancies), carefully evaluated in intermediate risk (25.42%), whereas a conservative approach can be adopted in low-risk patients (0.00%).CONCLUSIONS:
The integration of these two multiparametric systems in a Cyto-US score has proven to be a feasible and reliable aid to achieve a more accurate definition of malignancy risk.
Texto completo:
1
Coleções:
01-internacional
Temas:
Geral
Base de dados:
MEDLINE
Tipo de estudo:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Minerva Endocrinol (Torino)
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Itália